有膜的
- 与 有膜的 相关的网络例句 [注:此内容来源于网络,仅供参考]
-
Table 1 medical packaging materials, containers, scope of pharmaceutical packaging materials, containers, in the form of the name preparation notes plastic bottle kalidehydroandrogropholidi = 50ml material with PP, LDPE Infusion bags, kalidehydroandrogropholidi = 50ml material is PVC, polyalkene glass infusion bottle 50ml clorsulon = injection bottle kalidehydroandrogropholidi 50ml, kalidehydroandrogropholidi = 50ml-molded, control of glass bottle kalidehydroandrogropholidi kalidehydroandrogropholidi 50ml kalidehydroandrogropholidi 50ml ampule medical plastic bottle of tablets, capsules, tablets, colour.10pills glass ampoules, pills and capsules, syrup, oral solution, nanosuspensions, immunoembolization, tincture, linimentum, lotio hard PVC medicinal Tablet and capsule-plastic blister packaging PVC/PE/PVDC medicinal compound hard Tablet and capsule-plastic blister packaging Composite PVC/PVDC medicinal Tablet and capsule hard-plastic blister packaging cold metal forming hard medicinal compound tablets, capsules, suppository materials have nylon/aluminium/PVC double aluminum packaging Tablet and capsule PVC/hard LDPE medicinal compound tablets, capsules, suppository glass bottle ciinincal ciinincal ciinincal plastic bottle medicinal ciinincal medicinal eardrops plastic bottle eardrops medicinal nasal drops plastic bottle nose drops for external use liquid medicinal plastic bottle tincture, linimentum, lotio koufuye of medicinal plastic bottle syrup, oral solution, nanosuspensions, immunoembolization glass control oral bottle syrup, oral solution, nanosuspensions, immunoembolization packaging for medicine bag laminating film, puivis bletillae, feian and Tablet foil Tablet and capsule of unguentum Al fighting、smoke aluminium pipe, oculentum, puivis bletillae, Tin aerosolon, nabulization materials have aluminum, plastic valve pyritionate, nabulization stopple kalidehydroandrogropholidi 50ml, 50ml clorsulon = material bromide, CIIR synthesis of oprene 50ml clorsulon = gasket aluminium caps combination Cap koufuye falchion, kalidehydroandrogropholidi 50ml, 50ml prestrain kalidehydroandrogropholidi = potting needle kalidehydroandrogropholidi 50ml desiccant tablets, capsules, pills and aluminium bottles vinpocetione polyethylene film and bag vinpocetione b, package management and standards on the management of the drug packaging mainly has two modes: a mode of government management, such as Singapore, Indonesia adopted a market access system, United States, Canada, the European Union through the implementation of the medicine on the packaging of the strict management, that is, the drug registration, declare to use medical packaging of related materials; Government departments on the packaging manufacturer production system to carry out spot checks.
表1 药品包装材料、容器适用的范围药用包装材料、容器名称制剂形式备注塑料输液瓶注射剂≥50ml 材料有PP、LDPE 输液膜、袋注射剂≥50ml 材料有PVC、聚烯烃玻璃输液瓶注射剂≥50ml 冻干注射剂瓶注射剂0ml、注射剂≥50ml 模制、管制玻璃注射剂瓶注射剂0ml 安瓿注射剂0ml 口服固体药用塑料瓶片剂、胶囊、丸剂玻璃药瓶片剂、胶囊、丸剂、糖浆剂、口服溶液剂、混悬剂、乳剂、酊剂、搽剂、洗剂 PVC药用硬片片剂、胶囊铝塑泡罩包装 PVC/PE/PVDC药用复合硬片片剂、胶囊铝塑泡罩包装 PVC/PVDC药用复合硬片片剂、胶囊铝塑泡罩包装冷冲压成型药用复合硬片片剂、胶囊、栓剂材料有尼龙/铝/聚氯乙烯双铝包装片剂、胶囊 PVC/LDPE药用复合硬片片剂、胶囊、栓剂玻璃滴眼剂瓶滴眼剂药用滴眼剂塑料瓶滴眼剂药用滴耳剂塑料瓶滴耳剂药用滴鼻剂塑料瓶滴鼻剂外用液体药用塑料瓶酊剂、搽剂、洗剂口服液体药用塑料瓶糖浆剂、口服溶液剂、混悬剂、乳剂玻璃管制口服液瓶糖浆剂、口服溶液剂、混悬剂、乳剂药品包装用复合膜、袋散剂、颗粒剂、片剂药品包装用铝箔片剂、胶囊铝管、铝塑管软膏、眼膏剂、散剂、罐气雾剂、喷雾剂材料有铝、塑料阀门气雾剂、喷雾剂胶塞注射剂0ml、注射剂≥50ml 材料有溴化、氯化丁基橡胶合成聚异戊二烯垫片注射剂≥50ml 铝盖、铝塑组合盖口服液、注射剂0ml、注射剂≥50ml 预灌封注射针注射剂0ml 干燥剂片剂、胶囊、丸剂铝瓶原料药聚乙烯膜、袋原料药二、包装管理及标准各国对药品包装的管理主要有两种模式:一种模式是政府管理,如新加坡、印度尼西亚采取市场准入制的方式,美国、加拿大、欧盟通过对药品的管理实施对药品包装的严格管理即在药品注册时,申报所使用药品包装的相关材料;政府部门对药品包装生产企业的生产体系进行现场检查。
-
A variety of gram release paper, Glassine paper, kraft paper, double-plastic single silicon paper, double silicon paper, various kinds of imported Release Paper; a variety of PET-off membrane, a single silicon membrane, double-silicon film, the original membrane and white film, black film, membrane switch-specific membrane; all kinds of tape, double-sided tape, Burkina tape, police-style tape, kraft paper tape, textured paper tape, fiber tape; I Division sales PET release film has a different g weight-off edge, and can provide customers from the type of force production.
各种克重离型纸、格拉辛纸、牛皮纸、双塑单硅纸、双硅纸、各种进口离型纸;各种PET离型膜、单硅膜、双硅膜、原膜、白片、黑膜、薄膜开关专用膜;各种胶带、双面胶、布基胶带、警式胶带、牛皮纸胶带、美纹纸胶带、纤维胶带;我司销售的PET离型膜有不同克重的离型力,并可按客户提供的离型力生产。
-
Our main products are: 1, major equipment has: manually parallel Exposure Machine (5KW) Double-Sided Exposure Machine (8KW, 7KW, 5KW,) manual film laminated machine film machine noodle plate cleaning machine Net version of plate brown brown film developing machine exposure machine film machine Complex punching machines and other dried-way equipment circuit board. 2, agent Product categories: the brand special light sources and surrounding light machine fittings: 8K, 7K, 5K Exposure Machine lamp, quartz water jacket, exposure glass, Mylar membrane, ion filter cans, laminated machine equipment, fittings and other fittings.
公司主要产品有:1、主要设备有:◆手动平行曝光机(5KW)◆双面曝光机(8KW、7KW 、5KW,)◆手动压膜机◆底片贴膜机◆板面清洁机◆网版晒版机◆棕片显影机◆棕片曝光机◆复片机◆冲片机等线路板干制程设备。2、代理产品类:各厂牌特种光源及曝光机周边配件:8K、7K、5K 曝光机灯管,石英水套,曝光玻璃,Mylar膜,离子过滤罐,压膜机配件等设备的配件。
-
We extracted membrane protein of Mycoplasma hyopneumoniae MY-99 strain from its different passages strains MY-99l,MY-993 and rejuvenescence strain MY-992, then analyzed them by SDS-PAGE, the results show that the membrane protein of Mycoplasma hyopneumoniae MY-99 strain mutated during artificial culturing . According to the electrophoretic profiles, the membrane proteins of MY-991 include 7 protein bands: 94.4KD,57.5KD,46.0KD,36.0KD,32.4KD,20.4KD and 16.6KD.
采用0.4%TritonX-100结合KI提取猪肿炎支原体MY-99株不同代次的传代株MY-991、MY-993和复壮株MY-992的膜蛋白,并通过SDS-PAGE技术对其膜蛋白进行比较分析发现,在人工培养条件下猪肺炎支原体MY-99株的膜蛋白发生了一定的变异,其中MY-991株的膜蛋白有七条蛋白条带:94.4KD、57.5KD、46.0KD、36.0KD、32.4KD、20.4KD和16.6KD,MY-993株的膜蛋白有七条蛋白条带:94.4KD、57.5KD、46.0KD、41.0KD、36.0KD、32.4KD和19.5KD,MY-992株的膜蛋白只有两条蛋白条带:46.0KD和32.4KD。
-
There are two types of maturation according to our observation.One is nucleocapsids obtained its tegument in the nucleus and enveloped from the inner nuclear membrane.Another is nucleocapsids entered cytoplasm through nuclear membrane,then obtained their tegument in the cytoplasm,enveloped from the plasma membrane,finally released by necrosis,exocytosis or other ways.
病毒成熟有两种方式:一为细胞核内核衣壳在核内获得皮层,通过核内膜获得囊膜成为成熟病毒;二为核内核衣壳通过内外核膜进入胞浆,核内和胞浆内的核衣壳在细胞浆中获得皮层,然后在各种质膜上获得囊膜,最后成熟病毒通过细胞破裂或其他方式释放到细胞外。
-
ResultsOne of 18 cases with drill drainage got cured in hospital, others were uncured when leaving hospital.
18例钻孔引流患者中有1例的硬膜下积液在住院期间治愈,其余盎者硬膜下积液出院时未见减少,其中15例1~6个月随访积液好转或自愈,2例演变为慢性硬膜下血肿;另24例行保守治疗的患者,其中21例1~6个月随访积液好转或自愈,1例演变为慢性硬膜下血肿,2例积液扩大有颅高压表现者行开颅剥除包膜并打通外侧裂池,术后6个月后随访痊愈。
-
The result of immobilization showed that hydrophile membranes were more advantageous than hydrophobe ones to act as immobilization carrier. Crosslinking organophosphorus hydrolase by glutaraldehyde on polyethersulfone membrane is a simple and practical immobilization method. An appropriate amount of bovine serum albumin and crosslinker is necessary to get a good result of immobilization. In the biodegradation of methyl-parathion through enzyme membrane reactor, the effect of immobilized enzyme amount, flow rate of peristaltic pump, pH of the feed, and the methyl-parathion concentration on biodegradation rate was studied. It was shown that the biodegradation rate increased with immobilized enzyme amount and substrate concentration. Biodegradation rate didn't increase when the folw rate of the peristaltic pump was larger than 7 ml/min.
然后,研究固定化酶降解甲基对硫磷,从不同材料的膜载体固定有机磷水解酶的比较中,发现亲水膜比疏水膜适合作固定化酶载体;在此基础上,将有机磷水解酶固定在聚醚砜微滤膜上,并制成酶膜生物反应器,用于降解甲基对硫磷;戊二醛化学交联法固定时,酶液与10%牛血清白蛋白溶液的比例在3:1~2:1,与交联剂的比例在7:2~7:4范围内,固定化效果较好,并发现牛血清白蛋白和膜载体有降低酶活损失的作用;将固定化的酶膜装于酶膜反应器降解甲基对硫磷,实验结果表明:反应器的降解速率与固定化酶量呈正比,也随底物浓度的增加而加快,当流速低时,降解速率随流速增大而加快,到7ml/min以上时,降解速率不随流速脑黾佣洌到獾淖畹团ǘ任?
-
The cytochemical localization of POD showed that the peroxidase was found in cells ofboth cultivars after inoculation. The activity of POD in resistant cultivar was higher than that innot only the uninoculated controls but also the inoculated susceptible ones and localized morewidely, such as localized in mesophyll cell wall, intercellular spaces, membranes of chloroplastand mitochondrion and vacuolar membrane. Whereas the POD in susceptible cultivar waslocalized mainly in cell walls but little in plasma membrane with a lower range and intensitythan that in resistant cultivar.
对过氧化物酶的细胞定位研究发现,无论抗病杨树还是感病杨树,接种后均发现细胞中有过氧化物酶反应产物,通过分析发现,毛白杨过氧化物酶的活性不仅明显高于未接种的对照,也明显高于接种处理后的北京杨,并且定位更广泛,在细胞壁、细胞间隙、叶绿体膜、线粒体膜及液泡膜上均有大量定位,而北京杨酶反应产物主要分布于细胞壁上,在细胞膜、核膜局部有少量定位,定位范围及强度均小于毛白杨。
-
It can be used to make artificial dialysers,artificial skins,oral ulcer membranes,and periodontal tissue GTR membranes and drug membranes.
为对医药领域开发和研制壳聚糖膜提供一些借鉴,综述了壳聚糖膜可以应用于医药领域的优良性能:易降解性、生物相容性、促创伤愈合性、抗菌性和药物缓释性;以及壳聚糖膜剂的一些医药用途,有人工肾膜、人工皮肤、口腔溃疡膜、牙周 GTR膜、不同给药途径药膜等。
-
Some cell dropped into the cavity and became free. Thrombosis or part organization could be seen. The internal elastic layer became thin, disappear or broken. In internal and middle layer existed fibroblasts, fibrocytes and collagen. Some of the wall indicated hyaline change, soomth muscle cell decreased greatly. The massive inflammatory cells invaded the middle and external layer. There were many foam cells in the capsule tissue. Cytoplasm was filled with fatty tissue and cholesterol. some cavities were full of thrombosis. Some thrombosis was fibrosis, the bottom was organization. The surface of the thrombosis existed red blood cell and librae.(2)Elatic fibrila staining: the internal elastic menbrane almost completely disappeared, the intact internal elastic menbran could be seen in the new small vessels.
动脉瘤管壁厚薄明显不均,全层或局部区域显著变薄向外膨出,内皮细胞空泡变性或坏死脱落,部分内皮细胞剥离并突入管腔成游离状,可见血栓形成及部分血栓机化;内弹力板变薄、消失或突然中断;在内膜及中膜部位主要为纤维母细胞、纤维细胞和大片胶原;部分动脉瘤壁呈均质状玻璃样变,平滑肌细胞明显减少;中膜和外膜可见大量的炎性细胞浸润;瘤壁组织有纤维母细胞、纤维细胞、大片胶原成分及较多泡沫细胞,胞浆内充满脂类物质及胆固醇结晶;部分动脉瘤腔内充满血栓,有的血拴已经纤维化,血栓基部机化,血栓表面有红细胞和纤维素。
- 推荐网络例句
-
This one mode pays close attention to network credence foundation of the businessman very much.
这一模式非常关注商人的网络信用基础。
-
Cell morphology of bacterial ghost of Pasteurella multocida was observed by scanning electron microscopy and inactivation ratio was estimated by CFU analysi.
扫描电镜观察多杀性巴氏杆菌细菌幽灵和菌落形成单位评价遗传灭活率。
-
There is no differences of cell proliferation vitality between labeled and unlabeled NSCs.
双标记神经干细胞的增殖、分化活力与未标记神经干细胞相比无改变。